4.7 Article

Apolipoprotein B Is an Innate Barrier against Invasive Staphylococcus aureus Infection

Journal

CELL HOST & MICROBE
Volume 4, Issue 6, Pages 555-566

Publisher

CELL PRESS
DOI: 10.1016/j.chom.2008.10.001

Keywords

-

Funding

  1. NIAID NIH HHS [R01 AI037142, R01 AI064926-02, AI 37142, R01 AI064926-04, R01 AI064926-03, R01 AI047441, R01 AI064926-01, R01 AI064926, T32 AI007538, AI-064926, AI 47441] Funding Source: Medline

Ask authors/readers for more resources

Staphylococcus aureus is both a colonizer of humans and a cause of severe invasive infections. Although the genetic basis for phenotype switching from colonizing to invasive has received significant study, knowledge of host factors that antagonize the switch is limited. We show that VLDL and LDL lipoproteins interfere with this switch by antagonizing the S. aureus agr quorum-sensing system that upregulates genes required for invasive infection. The mechanism of antagonism entails binding of the major structural protein of these lipoproteins, apolipoprotein B, to an S. aureus autoinducing pheromone, preventing attachment of this pheromone to the bacteria and subsequent signaling through its receptor, AgrC. Mice deficient in plasma apolipoprotein 13, either genetically or pharmacologically, are more susceptible to invasive agr+ bacterial infection, but not to infection with an agr deletion mutant. Therefore, apolipoprotein B at homeostatic levels in blood is an essential innate defense effector against invasive S. aureus infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available